QDENGA: A Milestone in India’s Battle Against Dengue
The onset of monsoon in India apart from bringing relief from the sweltering heat marks the rise of dengue cases. Every year, lakhs of people infected by...
CBN India Seizes Illicit Trafficking of 12 Crore Tramadol Tablets under “Operation Vajra”
The Central Bureau of Narcotics (CBN) successfully executed “Operation Vajra,” seizing a massive export consignment of 120 million (12 crore) high-strength Tramadol Hydrochloride tablets....
DCGI Approves Qdenga, Marking India’s First Dengue Vaccine
Takeda Biopharmaceuticals India has received market authorisation from the Drug Controller General of India (DCGI) for Qdenga, making it the country's first licensed dengue vaccine....
NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib
Alembic Pharmaceuticals Limited announced that its development partner, NATCO Pharma Limited (NATCO), has received tentative approval from the U.S. Food and Drug Administration (USFDA)...
Eli Lilly Acquires AtaiBeckley to Accelerate Innovative Depression Treatments
Eli Lilly and Company and AtaiBeckley Inc. announced a agreement for Lilly to acquire AtaiBeckley. The transaction features cash consideration of $6.75 per share,...
AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
